Merck, riding clinical success, eyes cancer immunotherapy lead – BioPharma Dive
Miami Herald |
Merck, riding clinical success, eyes cancer immunotherapy lead
BioPharma Dive Merck & Co.'s flagship cancer drug Keytruda surpassed diabetes medicines Januvia and Janumet as the pharma's top-selling therapeutic franchise in the first quarter, underscoring the rapid sales growth of the immunotherapy over the past year. Sales of … Merck lifts earnings forecast after currency boost |
